StockNews.AI
CDXC
StockNews.AI
175 days

ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025

1. ChromaDex schedules 2024 earnings call on March 4, 2025 after market close. 2. Q4 and full-year 2024 financial results for NAD+ research and healthy aging discussed.

Earnings
+4.04%Current Return
VS
+0.04%S&P 500
$5.4402/25 04:50 PM EDTEvent Start
$5.6602/26 11:27 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Earnings calls are periodic events that can drive short-term volatility but offer no immediate surprises. Historically, similar announcements have had limited impact until detailed numbers are released.

How important is it?

Though standard, the earnings announcement is critical for investor updates and short-term trading decisions. Its cyclical nature tempers its overall market impact until results are concrete.

Why Short Term?

Earnings announcements typically affect stock prices in the near term as investors react to quarterly performance. Past earnings reports have shown immediate price adjustments on release.

Related Companies

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #2024Earnings--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces that it will hold a conference call on Tuesday, March 4, 2025, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year 2024 financial results, which ended December 31, 2024. The financial results will be reported in a press release after the close of regular stock market trading hours on Tu.

Related News